Session Overview:

As genomic medicine becomes part of everyday care, the NHS must ensure genomic information can move safely and meaningfully between laboratories, clinical systems and multidisciplinary teams.

This keynote will explore the role of data and digital infrastructure in enabling genomic medicine at scale, including the development of the Unified Genomic Record, the relationship between genomics and EPRs, and the standards, governance and interoperability required to make genomic insights accessible at the point of care.

Key themes:

• The strategic role of data and digital in genomic medicine.
• The Unified Genomic Record and its potential to support lifelong, patient-centred care.
• Connecting genomic laboratory systems, informatics platforms and local EPR environments.
• Making genomic results structured, shareable and clinically usable.
• Building the foundations for safe, scalable genomic medicine across the NHS.

Session Overview:

This practical skill clinic will focus on the core foundations needed to embed genomics into routine NHS services. The session will explore how organisations can align clinical pathways, digital infrastructure and workforce capability to support genomic test ordering, result interpretation and informed clinical decision-making.

Key themes:

• Mapping where genomic testing fits within existing clinical pathways and EPR workflows.
• Preparing electronic requesting, order management and reporting systems for genomic care.
• Designing clinician-friendly access to genomic results and decision support.
• Establishing clear data flows between genomic laboratories, digital teams and frontline services.
• Reducing complexity for already stretched clinical teams.
• Building readiness for the wider adoption of genomic medicine.

Case Study - C the Signs

Session Overview:

C the Signs is helping shift cancer care from reactive diagnosis towards proactive, population-level detection across the NHS.

This session explores the next step: extending established cancer case-finding infrastructure further upstream to identify people at increased hereditary breast cancer risk.

Across multiple ICBs, C the Signs proactively searches primary care populations and invites eligible patients to complete a digital risk assessment, rather than relying on family history being identified during a consultation.

Detailed family history is captured and integrated with CANRISK to calculate breast cancer risk. Patients can then be navigated to the appropriate pathway, from reassurance and routine care to enhanced surveillance, clinical genetics, counselling and genetic testing.

The project demonstrates how technology already deployed at NHS scale can create a practical, scalable route into genomic and preventative services, identifying inherited risk earlier, before cancer develops.

A patient voice recording sharing their personal experiences, perspectives, and insights of their care journey.

Session Overview:

This leadership interview will explore the operational and cultural challenges of bringing genomic medicine into everyday NHS care.

Discussion will focus on how leaders can align clinical, genomic, digital and informatics teams; build confidence among clinicians; manage change across complex pathways; and ensure new systems genuinely improve care rather than add administrative burden.

Key themes:

• Leading change across clinical, diagnostic and digital boundaries.
• Building effective partnerships between genomic services, EPR teams and frontline clinicians.
• Supporting adoption of new digital workflows and decision-support tools.
• Creating confidence in the use, interpretation and sharing of genomic information.
• Lessons from delivering sustainable genomic transformation at scale.

Session Overview:

This NHS deep dive will explore how genomic testing can be embedded into existing clinical pathways without adding unnecessary complexity for clinicians or patients.

The session will focus on the practical steps required to support electronic test ordering, referral processes, result management, multidisciplinary working and the use of genomic insight within local EPR environments.

Key themes:

• Embedding genomic testing into routine clinical and EPR workflows.
• Improving electronic requesting, referral and order-management processes.
• Ensuring genomic results are delivered in clinically usable formats.
• Supporting multidisciplinary interpretation and decision-making.
• Connecting local delivery with national genomic infrastructure.
• Lessons for scaling genomic testing across specialties.

A patient voice recording sharing their personal experiences, perspectives, and insights of their care journey.

Session Overview:

Genomic research continues to advance rapidly, but translating innovation into meaningful clinical action remains a universal challenge. Drawing on his experience across clinical practice, research and innovation, Videha Sharma will explore how healthcare systems can close this implementation gap and ensure genomic discoveries deliver tangible benefits for patients.

The session will examine the importance of building interoperability into services by design, creating effective mechanisms for sharing best practice and moving successful innovations beyond isolated projects. It will consider what is required to embed genomic evidence into clinical decision-making and develop connected, scalable approaches that work across different organisations, specialties and care settings.

Session Overview:

This case study will explore how NHS Scotland and their ANIA (Accelerated National Innovation Adoption pathway) is using rapid pharmacogenetic testing to prevent avoidable hearing loss in newborn babies receiving gentamicin.

The session will examine how a simple bedside cheek swab can identify babies at genetic risk within around 26 minutes, enabling clinicians to make safer prescribing decisions without delaying urgent treatment.

It will explore the practical journey from innovation to national implementation, including the integration of genomic testing into time-critical neonatal pathways and the collaboration required to deliver change across NHS Scotland.

Key themes:

• Embedding pharmacogenetic testing into urgent neonatal care pathways.
• Using point-of-care testing to support safer, personalised prescribing.
• Integrating genomic insight into clinical decision-making without delaying treatment.
• Lessons from implementing a nationally coordinated pathway across NHS Scotland Health Boards.
• Bringing together clinicians, pharmacists, laboratory, genomics and digital teams to deliver change.
• The potential for this model to support wider adoption of personalised medicine.

Session Overview:

• Building genomic literacy and confidence among nurses and midwives.
• Enabling nurses to identify and support appropriate genomic testing in cardiology.
• Communicating genomic testing, consent and results with patients and families.
• Using genomic insights and digital decision support in clinical practice.
• Embedding genomic testing safely and effectively into routine care pathways.

A patient voice recording sharing their personal experiences, perspectives, and insights of their care journey.